WIF-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of WIF-1 monoclonal antibodies for investigating Wnt inhibitory factor 1 (WIF-1) in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WIF-1 plays a significant role in regulating Wnt signaling pathways, which are essential for cell proliferation, differentiation, and embryonic development. Dysregulation of WIF-1 has been implicated in various diseases, including cancer, making it an important target for research. Understanding WIF-1 function can provide insights into therapeutic strategies for conditions associated with aberrant Wnt signaling. Researchers can utilize WIF-1 monoclonal antibodies to examine protein expression patterns across different tissue types. Advanced visualization options include conjugates with horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Santa Cruz Biotechnology monoclonal antibodies for WIF-1 enable researchers worldwide to advance their understanding of cellular signaling mechanisms and potential therapeutic applications.